Kelun’s Merck-partnered ADC snags first nod in China to kick off TROP2 fight with Gilead
November 27, 2024Sanofi charts biggest China investment to date with plans for €1B insulin ‘manufacturing base’ in Beijing
December 2, 2024Race is on for oral obesity drugs with multiple phase 3 trials vying for next-gen status in a $126B market
badams
Mon, 12/02/2024 – 04:30
